NOBLEOAK LIFE LIMITED (NOL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NOL - NOBLEOAK LIFE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.65

20 Dec
2024

-0.005

OPEN

$1.61

-0.30%

HIGH

$1.65

14,463

LOW

$1.60

TARGET
$2.85 72.7% upside
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
NOL: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx 10.8 19.2 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx 15.6% 78.4% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 8.6 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx10.8
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx386.6 M
Book Value Per Share xxxxxxxxxxxxxxx82.7
Net Operating Cash Flow xxxxxxxxxxxxxxx44.4 M
Net Profit Margin xxxxxxxxxxxxxxx2.40 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx9.71 %
Return on Invested Capital xxxxxxxxxxxxxxx9.23 %
Return on Assets xxxxxxxxxxxxxxx2.60 %
Return on Equity xxxxxxxxxxxxxxx9.71 %
Return on Total Capital xxxxxxxxxxxxxxx13.38 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx44.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx5 M
Total Debt xxxxxxxxxxxxxxx5 M
Goodwill - Gross xxxxxxxxxxxxxxx0 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx64 M
Price To Book Value xxxxxxxxxxxxxxx1.74

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.10 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx76 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx208 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

27/11/2024

1

Buy, High Risk

$2.85

72.73%

As part of NobleOak Life's AGM trading update, management stated claims experience is in line with expectations, and margins are expected to remain stable, notes Shaw and Partners.

For the first four months of FY25, in-force (currently active) annualised premium growth of 19% is outperforming both guidance and the broker's 15% forecast.

No changes are made to forecasts. The Buy, High Risk rating and $2.85 target are maintained.

FORECAST
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 19.20 cents.
Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 21.50 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

NOL STOCK CHART